Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Novartis Pharmaceuticals · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
adultmsrelapse
relapsing multiple sclerosis, ms, rms, rrms, active secondary progressive multiple sclerosis spms, remibrutinib, lou064, teriflunomide, adult, relapse, expanded disability status scale, t2 lesions
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 966387
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.